Vahid Sadeghi-Firoozabadi; Haniyeh Khosh; Mohsen Dehghani; Ali khatibi; AbdolReza Nasser Moghaddasi; Vahid abdolmanafi
Abstract
Objective: This research was conducted with the aim of studying the role of sleep quality moderator in the relationship between depression and treatment compliance. Method: The research design was descriptive and correlational and the community included all patients with multiple sclerosis living in ...
Read More
Objective: This research was conducted with the aim of studying the role of sleep quality moderator in the relationship between depression and treatment compliance. Method: The research design was descriptive and correlational and the community included all patients with multiple sclerosis living in Tehran. 229 subjects with Multiple Sclerosis disease were selected in the accessible way and they were asked to answer Morinsky's treatment compliance, Petersburg sleep quality and Beck's depression questionnaires using pencil and paper method. Findings: Evidence of the predictive role of depressive symptoms for poor adherence to treatment in patients with multiple sclerosis was found. In addition, evidence of the predictive role of sleep quality in treatment adherence was found, but its mediating role in the relationship between depression and treatment adherence was not found. Conclusion: The findings indicated the importance of depression symptoms and sleep quality in the treatment compliance of multiple sclerosis patients. Considering the importance of treatment compliance in the prognosis of the disease, it is suggested that doctors take this issue into consideration to formulate treatment plans to target cognitive and emotional problems parallel to the main treatment of the disease and thereby increase treatment compliance.
